Kristen Gilroy
Family Medicine · Rock Hill, SCNPI 1184476749
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.5% of the total across 180 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AstraZeneca at 26.4% of the total.
Across 180 payments — averaging $23.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Regeneron Healthcare Solutions, Inc.$524
- GSK$486
- Mallinckrodt Hospital Products Inc.$255
- Sanofi$235
- Verona Pharma, Inc.$173
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,89794%
- Education$2696%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 43 | $1,102 |
| Regeneron Healthcare Solutions, Inc. | 16 | $524 |
| GSK | 26 | $486 |
| Mallinckrodt Hospital Products Inc. | 13 | $255 |
| Sanofi | 11 | $235 |
| Verona Pharma, Inc. | 10 | $173 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $150 |
| Novartis | 7 | $129 |
| Insmed, Inc. | 7 | $122 |
| CSL Behring | 5 | $116 |
| Actelion Pharmaceuticals US, Inc. | 4 | $109 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| United Therapeutics Corporation | 3 | $97 |
| Amgen | 3 | $69 |
| Boehringer Ingelheim | 4 | $68 |
| Grifols USA, LLC | 3 | $59 |
| Pfizer | 2 | $55 |
| Merck | 2 | $48 |
| Inogen, Inc. | 1 | $43 |
| Azurity Pharmaceuticals, Inc. | 2 | $42 |
| Philips North America LLC | 2 | $33 |
| Mylan Specialty L.p. | 2 | $31 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $27 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Viatris Specialty LLC | 1 | $24 |
| Genentech USA, Inc. | 1 | $23 |
| Ionis Pharmaceuticals, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,167 in reported general payments places this provider in the 80th percentile of 2,153 family medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 20 | $415 |
| Montelukast Sodium | 13 | $30 |
| Prednisone | 14 | $23 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Rock Hill
- Stephen BruntonWinnsboro$1.3M
- Richard WilkesMt Pleasant$216K
- Andrew MartinColumbia$205K
- Ada StewartColumbia$186K
- Jeffrey BroderNorth Augusta$140K
- Terry NagelColumbia$112K
- Katherine JohnsonGreenwood$80K
- Scott SmithMount Pleasant$68K
- Jennifer StolinSummerville$59K
- Nicholas PenningsNorth Myrtle Beach$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.